For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Updates for markets open

By Johann M Cherian and Sukriti Gupta

Jan 13 (Reuters) - U.S. stocks dropped on Monday, with the benchmark S&P 500 at a two-month low as bond yields surged after robust payroll numbers last week, boosting expectations that the Federal Reserve will maintain a hawkish stance for most of this year.

At 09:50 a.m. the Dow Jones Industrial Average .DJI rose 105.06 points, or 0.25%, to 42,043.51, the S&P 500 .SPX lost 40.79 points, or 0.70%, to 5,786.25, and the Nasdaq Composite .IXIC lost 274.13 points, or 1.43%, to 18,887.50.

Wall Street's fear gauge .VIX rose 1.60 points to hit a more than three-week high.

The domestically sensitive Russell 2000 index .RUT declined 1% to its lowest since September 2024, extending Friday's decline, which saw it enter correction territory after falling more than 10% from its November intraday record high.

Pressuring stocks, yields on longer-dated Treasury bonds US10YT=RR, US30YT=RR are pinned at multi-month highs. US/

At one point, traders were no longer fully pricing in even one Fed rate cut this year, according to data compiled by LSEG , from about 43 basis points before Friday's job figures. Bets currently reflect expectations of a 27 bps easing by the Fed's December meeting.

"In the early stages of recalibrating monetary policy, investors tend to take a bit of a risk-off attitude," said Art Hogan, chief market strategist at B Riley Wealth.

"But the important part of what has changed thus far this year is that economic data being positive at the end of the day will likely be a net positive for corporate earnings and for markets."

Five of the 11 S&P 500 sectors declined, led by a 1.8% drop in Technology stocks .SPLRCT. Megacaps were down, with Tesla TSLA.O sliding 2%, Apple AAPL.O dropping 2.7% and Alphabet GOOGL.O losing 1.5%.

The main indexes logged their second consecutive week of declines in the previous session after multiple reports pointed to better-than-expected economic activity, raising worries that inflation could be running high.

Investors also priced in the likelihood that the incoming Donald Trump administration's policies - such as tariffs and a clampdown on illegal immigration - could threaten global trade and fuel price pressures when the Fed has also signaled a cloudy monetary policy outlook. Trump is expected to take office on Jan. 20.

The Consumer Price Index numbers and the central bank's Beige Book on economic activity, both due on Wednesday, could help investors gauge the Fed's policy outlook.

Chip stocks such as Nvidia NVDA.O dropped 3.3% and Advanced Micro Devices AMD.O fell 1% after the U.S. government said it would further restrict artificial-intelligence chip and technology exports.

Moderna MRNA.O slid 22% to the bottom of the S&P 500 after cutting its 2025 sales forecast by $1 billion.

Dow component UnitedHealth Group UNH.N added 3.6%, CVS Health CVS.N rose 4.1% and Humana HUM.N climbed 5.9% after the U.S. government proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers, which will result in a 2.2% increase in payments.

Major lenders JPMorgan Chase & Co JPM.N and Wells Fargo WFC.N are due to report results on Wednesday.

Declining issues outnumbered advancers by a 1.96-to-1 ratio on the NYSE, and by a 2.57-to-1 ratio on the Nasdaq.

The S&P 500 posted one new 52-week high and 22 new lows, while the Nasdaq Composite recorded 11 new highs and 149 new lows.

(Reporting by Johann M Cherian and Sukriti Gupta in Bengaluru; Editing by Pooja Desai)

((johann.mcherian@thomsonreuters.com;))